[Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Yamaguchi
Motoko
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007564:Japan; D007694:Killer Cells, Natural; D007723:Korea; D016399:Lymphoma, T-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D009669:Nose Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000532:radiotherapy*; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D005047:Etoposide; D003907:Dexamethasone; D016190:Carboplatin; D007069:Ifosfamide